Late-breaking data presented at the 2023 aad annual meeting demonstrates improved accuracy of decisiondx®-scc in predicting metastatic risk over traditional staging systems in independent, multi-center cohort study

Friendswood, texas--(business wire)---- $cstl #cstl--castle shared new data demonstrating how the independent risk-stratification of decisiondx®-scc can significantly improve metastatic risk predictions.
CSTL Ratings Summary
CSTL Quant Ranking